Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03829787 · ClinicalTrials.gov registry record
Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder
A clinical trial of Bipolar Disorder, sponsored by University Hospitals Cleveland Medical Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT03829787 is a study of Bipolar Disorder that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 100 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03829787, a study of Bipolar Disorder, is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to use eye-tracking technology to study attentional biases, reward sensitivity, and cognitive control in adult patients with bipolar disorder with or without anxiety and/or substance use disorder comorbidity.
Conditions Studied
Interventions
- DEVICE Eye tracking
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Mood Disorders Program - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-03-27 |
| Est. Completion | 2026-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03829787
The ClinicalTrials.gov registry entry for NCT03829787 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (70% lower). The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 1 intervention - of which Eye tracking is the first listed.
NCT03829787 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03829787 about?
NCT03829787 is a clinical study titled "Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder". The purpose of this study is to use eye-tracking technology to study attentional biases, reward sensitivity, and cognitive control in adult patients with bipolar disorder with or without anxiety and/or substance use disorder comorbidity.
What is the current status of trial NCT03829787?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2019-03-27. Estimated completion is 2026-09-01.
What conditions does trial NCT03829787 study?
This clinical trial studies the following conditions: Bipolar Disorder.
What interventions are being tested in trial NCT03829787?
The interventions under investigation include: Eye tracking (DEVICE).
Who is sponsoring clinical trial NCT03829787?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03829787 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
RECRUITING · Phase 3
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
RECRUITING · Phase 2
-
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder
RECRUITING · Phase 2
-
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.